Log In
BCIQ
Print this Print this
 

Hemofil M

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionAntihemophilic factor (AHF)
Molecular Target Factor VIII
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsPrevent and control hemorrhagic episodes in patients with hemophilia A
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today